In the BioHarmony Drug Report Database
Ropeginterferon alfa-2b
Besremi (ropeginterferon alfa-2b) is an unknown pharmaceutical. Ropeginterferon alfa-2b was first approved as Besremi on 2019-02-15. It has been approved in Europe to treat polycythemia vera.
Trade Name
|
Besremi |
|---|---|
Common Name
|
ropeginterferon alfa-2b |
ChEMBL ID
|
CHEMBL4297819 |
Indication
|
polycythemia vera |
Drug Class
|
Pegylated compounds |
Image (chem structure or protein)
